XML 64 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMON STOCK AND EARNINGS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2023
COMMON STOCK AND EARNINGS PER SHARE  
Schedule of computation of earnings per share

The following is a reconciliation of basic and diluted earnings per common share for each of the periods presented (in thousands, except share and per share data):

Year Ended

December 31,
2023

    

December 31,
2022

    

December 31,
2021

Basic and Diluted Earnings:

Net Income (Loss) Attributable to Common Stockholders, Used in Basic EPS

$

758

$

(1,623)

$

27,615

Add Back: Effect of Dilutive Interest Related to 2025 Notes (1)

Net Income (Loss) Attributable to Common Stockholders, Used in Diluted EPS

$

758

$

(1,623)

$

27,615

Basic and Diluted Shares:

Weighted Average Shares Outstanding, Basic

22,529,703

18,508,201

17,676,809

Common Shares Applicable to Dilutive Effect of 2025 Notes (2)

Weighted Average Shares Outstanding, Diluted

22,529,703

18,508,201

17,676,809

Per Share Information:

Net Income (Loss) Attributable to Common Stockholders

Basic and Diluted

$

0.03

$

(0.09)

$

1.56

(1)As applicable, includes interest expense, amortization of discount, amortization of fees, and other changes in net income or loss that would result from the assumed conversion of the 2025 Convertible Senior Notes to derive FFO effective January 1, 2022 due to the implementation of ASU 2020-06 which requires presentation on an if-converted basis. For the years ended December 31 2023 and 2022, a total of $2.1 million and $2.2 million of interest, respectively, was not included as the impact of the 2025 Notes, if-converted, would be antidilutive to the net income (loss) attributable to common stockholders in each respective period.
(2)A total of 3.3 million shares and 3.1 million shares, representing the dilutive impact of the 2025 Notes, upon adoption of ASU 2020-06 effective January 1, 2022, were not included in the computation of diluted net loss attributable to common
stockholders for the years ended December 31, 2023 or 2022, respectively, because they were antidilutive to the net income (loss) attributable to common stockholders in each respective period.